The trivalent vaccine contains three LAIV strains: H1N1- and H3N2-based LAIV viruses with insertion of the previously developed SARS-CoV-2 T-cell cassette into the NA segment of the influenza virus [6,7], and the unmodified influenza B/Victoria LAIV strain recommended for current influenza vaccines. The gene discussed is XK; the disease is influenza.